Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2020-01-27
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective of the study:
Clinical feasibility of the urine collection device, indicated by staff and parents.
Study design:
The study will be an open label, clinical feasibility study, of the urine collection device. During a period of 6 months, 30 feasibility tests will be performed.
Study population:
Prematurely born newborns, admitted to the neonatology unit of the department of pediatrics at Rijnstate Hospital Arnhem.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Renal Failure in Children With Urinary Tract Infections
NCT00316043
Quick-Wee Versus Bladder Stimulation System to Collect Midstream Urine From Pre-continent Infants
NCT04587999
Acute Kidney Injury in Children Operated for Congenital Heart Disease
NCT01316497
Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
NCT02419339
Applicability of Uroflowmetry in Children with Cerebral Palsy
NCT05017415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urinary collecting device
Urinary collecting device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Defective skin in genital region
* Three previous tests in the same subject
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fonds NutsOhra
OTHER
FrieslandCampina
INDUSTRY
Rijnstate Hospital
OTHER
Scint B.V.
UNKNOWN
Hertog Hendrik BV
UNKNOWN
University of Twente
OTHER
Radboud University Medical Center
OTHER
Capturin Distribution B.V.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Petra Van Setten
Arnhem, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL55778.091.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.